Semaglutide was equally effective for obesity in patients with or without IBD, with a more than 5% mean weight loss and no increased risk for disease-specific adverse events.
Related Keywords
Florida , United States , Aakash Desai , Division Of Gastroenterology , Mayo Clinic , Inflammatory Bowel ,
comparemela.com © 2020. All Rights Reserved.